106 research outputs found
Calibration of Troitsk nu-mass detector readout electronics by signal digital filters
We present the results of tuning and calibration of the detector electronics
in the signal digitization mode. The goal of the experiment is to search for a
possible sterile neutrino signature in tritium beta-decay. The read-out
electronics work in direct oscilloscope mode, which requires to optimize time
frame the with the goal to minimize noise and energy resolution. We use a
7-pixel silicon drift detector (SDD) and a CMOS charge sensitive preamplifier
with very low integration capacitor. Amplifier forms a slowly rising output
shape and operates in pulse-reset mode. The 125 MHz ADC digitizes the signals.
Using calibration data from Fe55 and Am241 gamma sources we check triangular
and trapezoid digital filters to obtain the best noise and energy resolution
performance. We are also examining the option to differentiate the output
signal.Comment: 9 pages, 8 figure
ΠΡΠΊΡΡΡΡΠ²Π΅Π½Π½Π°Ρ Π²Π΅Π½ΡΠΈΠ»ΡΡΠΈΡ Π»Π΅Π³ΠΊΠΈΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΌΠΎΡΠ±ΠΈΠ΄Π½ΡΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΡΠΈ Π»Π°ΠΏΠ°ΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΡΡ Π² ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΠΈ Π’ΡΠ΅Π½Π΄Π΅Π»Π΅Π½Π±ΡΡΠ³Π° (ΠΎΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ)
Β Β The literature review is devoted to the peculiarities of artificial lung ventilation (ALV) in patients with morbid obesity during laparoscopic oncosurgical interventions in the Trendelenburg position. At present, there are no consensus recommendations on the choice of the optimal ALV mode during anesthesia in this area of oncosurgery. When analyzing data obtained from other types of operations, there was no impression that there were significant advantages of any ALV modes, both with volume and pressure control. However, high values of positive end-expiratory pressure (PEEP) have the most evidence of benefit in this category of patients, and the inversion of the duration of the respiratory cycle phases without creating a high PEEP can help reduce the risk of lung damage when all other ALV techniques do not allow for adequate oxygenation.Β Β ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ Π²Π΅Π½ΡΠΈΠ»ΡΡΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
(ΠΠΠ) Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΌΠΎΡΠ±ΠΈΠ΄Π½ΡΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΡΠΈ Π»Π°ΠΏΠ°ΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠ½ΠΊΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π°Ρ
Π² ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΠΈ Π’ΡΠ΅Π½Π΄Π΅Π»Π΅Π½Π±ΡΡΠ³Π°. Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΡΠΎΠ³Π»Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΈ ΠΏΠΎ Π²ΡΠ±ΠΎΡΡ ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΆΠΈΠΌΠ° ΠΠΠ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π°Π½Π΅ΡΡΠ΅Π·ΠΈΠΈ Π² ΡΡΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ ΠΎΠ½ΠΊΠΎΡ
ΠΈΡΡΡΠ³ΠΈΠΈ ΠΎΡΡΡΡΡΡΠ²ΡΡΡ. ΠΡΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ Π΄Π°Π½Π½ΡΡ
, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈ Π΄ΡΡΠ³ΠΈΡ
Π²ΠΈΠ΄Π°Ρ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ, Π½Π΅ ΡΠ»ΠΎΠΆΠΈΠ»ΠΎΡΡ Π²ΠΏΠ΅ΡΠ°ΡΠ»Π΅Π½ΠΈΡ ΠΎ Π½Π°Π»ΠΈΡΠΈΠΈ Π·Π½Π°ΡΠΈΠΌΡΡ
ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ² ΠΊΠ°ΠΊΠΈΡ
-Π»ΠΈΠ±ΠΎ ΡΠ΅ΠΆΠΈΠΌΠΎΠ² ΠΠΠ β ΠΊΠ°ΠΊ Ρ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΏΠΎ ΠΎΠ±ΡΠ΅ΠΌΡ, ΡΠ°ΠΊ ΠΈ ΠΏΠΎ Π΄Π°Π²Π»Π΅Π½ΠΈΡ. Π’Π΅ΠΌ Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ Π±ΠΎΠ»ΡΡΠ΅ Π²ΡΠ΅Π³ΠΎ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡΡΠ² Π² ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΈ ΠΏΠΎΠ»ΡΠ·Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Ρ ΡΠ°ΠΊΠΎΠΉ ΠΊΠ°ΡΠ΅Π³ΠΎΡΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΠΌΠ΅ΡΡ Π²ΡΡΠΎΠΊΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΡ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π°Π²Π»Π΅Π½ΠΈΡ Π² ΠΊΠΎΠ½ΡΠ΅ Π²ΡΠ΄ΠΎΡ
Π° (ΠΠΠΠ), ΠΈΠ½Π²Π΅ΡΡΠΈΡ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΡΠ°Π· Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠΊΠ»Π° Π±Π΅Π· ΡΠΎΠ·Π΄Π°Π½ΠΈΡ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΠΠΠΠ ΠΌΠΎΠΆΠ΅Ρ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°ΡΡ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΈΡΠΊΠ° ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ Π»Π΅Π³ΠΊΠΈΡ
Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
, ΠΊΠΎΠ³Π΄Π° Π²ΡΠ΅ ΠΎΡΡΠ°Π»ΡΠ½ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΠΈ ΠΠΠ Π½Π΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ Π΄ΠΎΠ±ΠΈΡΡΡΡ Π°Π΄ΠΊΠ΅Π²Π°ΡΠ½ΠΎΠΉ ΠΎΠΊΡΠΈΠ³Π΅Π½Π°ΡΠΈΠΈ
ΠΠ°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΠ΅ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΎΠΏΡΡ ΠΎΠ»ΠΈ ΡΠΈΡΠ½ΠΈΠΊΠ°
Background. Hereditary genetic mutations are a significant risk factor for malignant transformation of cells and cancer development. Hereditary genetic mutations account for 15 to 25 % of all ovarian carcinomas. Purpose of the study: to summarize data on hereditary ovarian malignancies, namely: genetic defects, features of the clinical course, treatment options, and disease prevention. Material and methods. A systemic search was undertaken using PubMed, Medline, Cochrane Library databases for publications from 1999 to 2021. Results. The review describes the main genetic defects and hereditary cancer syndromes predisposing to the development of hereditary malignant ovarian tumors. The features of the clinical course and response to drug therapy have been presented. This article summarizes clinical guidelines of the professional communities (National Comprehensive Cancer Network (NCCN), American Society Of Clinical Oncology (ASCO), The U.S. Preventive Services Task Force, and European Society For Medical Oncology (ESMO). These guidelines contain early detection strategies and approaches to prevent the development of cancers in mutation carriers. Conclusion. Detection of hereditary cancer syndromes is important for patients and their families. Recognizing hereditary predisposition to cancer is important to allow timely surveillance and preventative interventions for both patients and family members.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠΠ°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΠ΅ Π΄Π΅ΡΠ΅ΠΊΡΡ Π³Π΅Π½ΠΎΠ² β Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΠΉ ΡΠ°ΠΊΡΠΎΡ ΡΠΈΡΠΊΠ° Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ. ΠΠ° Π΄ΠΎΠ»Ρ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠΎΡΠΌ ΠΏΡΠΈΡ
ΠΎΠ΄ΠΈΡΡΡ 15β25 % Π²ΡΠ΅Ρ
ΡΠ»ΡΡΠ°Π΅Π² ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌ ΡΠΈΡΠ½ΠΈΠΊΠ°. Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΠ±ΠΎΠ±ΡΠΈΡΡ ΠΈΠΌΠ΅ΡΡΠΈΠ΅ΡΡ Π΄Π°Π½Π½ΡΠ΅ ΠΎ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΡ
Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
ΡΠΈΡΠ½ΠΈΠΊΠΎΠ²: Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π΄Π΅ΡΠ΅ΠΊΡΠ°Ρ
, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ, Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΎΠΈΡΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΡ
ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΎΠ² Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΡΡ Π² Π±Π°Π·Π°Ρ
PubMed, Medline, Cochrane Library, Π²ΠΊΠ»ΡΡΠ°Π»ΠΈΡΡ ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΈ Ρ 1999 ΠΏΠΎ 2021 Π³. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΏΠΈΡΠ°Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π΄Π΅ΡΠ΅ΠΊΡΡ ΠΈ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Ρ Π½ΠΈΠΌΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠ΅ ΡΠΈΠ½Π΄ΡΠΎΠΌΡ, ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»Π°Π³Π°ΡΡΠΈΠ΅ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΡ
Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ ΡΠΈΡΠ½ΠΈΠΊΠ°. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΈ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΊ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. ΠΠ±ΠΎΠ±ΡΠ΅Π½Ρ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΈ ΠΏΡΠΎΡΠ΅ΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ
ΡΠΎΠΎΠ±ΡΠ΅ΡΡΠ²: ΠΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠΈ Π‘Π¨Π (National Comprehensive Cancer Network, NCCN), ΠΠΌΠ΅ΡΠΈΠΊΠ°Π½ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΡΡΠ²Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ (American Society Of Clinical Oncology, ASCO), Π Π°Π±ΠΎΡΠ΅ΠΉ Π³ΡΡΠΏΠΏΡ ΠΏΠΎ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Π² Π‘Π¨Π (The U.S. Preventive Services Task Force), ΠΠ²ΡΠΎΠΏΠ΅ΠΉΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΡΡΠ²Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ (European Society For Medical Oncology, ESMO), Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΠ΅ Π½Π° ΡΠ°Π½Π½Π΅Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ, ΠΈ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅Ρ Π΄Π»Ρ ΠΏΡΠ΅Π΄ΠΎΡΠ²ΡΠ°ΡΠ΅Π½ΠΈΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ ΡΠΈΡΠ½ΠΈΠΊΠ° Ρ Π½ΠΎΡΠΈΡΠ΅Π»Π΅ΠΉ Π³Π΅ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΡΡ
ΠΌΡΡΠ°ΡΠΈΠΉ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠ² ΠΈΠΌΠ΅Π΅Ρ Π²Π°ΠΆΠ½ΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈ ΠΈΡ
ΡΠ΅ΠΌΠ΅ΠΉ. Π‘Π²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΠΏΡΠΈΠΌΠΈΠ·ΠΈΡΠΎΠ²Π°ΡΡ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΡ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³Π° ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ
LAPAROSCOPIC SURGERY IN TREATMENT OF ENDOMETRIAL CANCER (RESULTS OF 7-YEAR CLINICAL EXPERIENCE AT THE N.N. PETROV NATIONAL MEDICAL RESEARCH ONCOLOGY CENTER)
Introduction. The main method of treatment of endometrial cancer, the most common oncological disease, is surgery. Introduction of high-tech operations into gynecological practice promoted active use of laparoscopy in treatment of malignant tumors of the endometrium.Objective. To evaluate effectiveness of video endoscopic surgery in treatment of endometrial cancer.Materials and methods. In the period from 2010 to 2016, 1127 patients with endometrial cancer underwent surgery using video endoscopic complex with high resolution cameras at the N.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia.Results.Β Using video endoscopic technology, excision of the uterus with appendages was performed in 588 (52.3 %) patients, excision of the uterus with appendages and pelvic lymph node dissection was performed in 523 (46.4 %) patients including 16 (1.4 %) patients with serous and papillary serous forms of endometrial cancer who also underwent omentectomy. No intraoperative complications were observed. In the majority of patients, postoperative period was characterized by early activization, satisfactory intestinal peristalsis on day 1, minimal complications, absence of contraindications for adjuvant beam therapy.Conclusion. Video endoscopic technology is a modern method of surgical treatment allowing to perform the full scope of planned radical surgical intervention in patients with endometrial cancer irrespectively of age and concomitant disorders with minimal traumatization, risk of intraand postoperative complications as well as favorable and fast rehabilitation period
ΠΠΈΠΊΡΠΎΠ ΠΠ, ΠΠΠ§-ΠΠΠ€ΠΠΠ¦ΠΠ― Π Π¦ΠΠ ΠΠΠΠΠΠ¬ΠΠ«Π ΠΠΠΠ¦ΠΠ ΠΠΠΠΠΠ: ΠΠΠΠΠΠ£ΠΠ―Π ΠΠ«Π ΠΠ‘ΠΠΠΠ’Π« Π ΠΠΠ Π‘ΠΠΠΠ’ΠΠΠ« ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠΠ ΠΠ‘ΠΠΠΠ¬ΠΠΠΠΠΠΠ―
Cervical cancer is one of the most common cancers of the female reproductive system and a leading cause of mortality in women worldwide. Epidemiologic and experimental data have clearly demonstrated a causal role of Human Papillomavirus in cervical carcinogenesis. Determination of HPV DNA of high carcinogenic risk is relevant screening tool to identify patients with an increased risk of cervical neoplasia. However, the positive predictive value of such an analysis is not high enough. Analysis of additional indicators of infection (viral load, the ratio of episomal and integrated forms of the virus, the duration of its persistence) can be used to improve the diagnostic and prognostic value of HPV testing. In the last decade, studies have shown that HPV induces specific changes in miRNA profile of the infected cell, which reflect the phasing of the disease and may have diagnostic / prognostic value. This review summarizes the current understanding of cellular changes in the profile of microRNAs, caused by infection with HPV, given the known examples of microRNA involvement in cervical carcinogenesis and the perspectives of the possible use of microRNAs as biomarkers in the diagnosis of cervical cancer.Π Π°ΠΊ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ (Π Π¨Π) ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· ΡΠ°ΠΌΡΡ
ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΡ
ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΆΠ΅Π½ΡΠΊΠΎΠΉ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΈ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· Π»ΠΈΠ΄ΠΈΡΡΡΡΠΈΡ
ΠΏΡΠΈΡΠΈΠ½ ΠΆΠ΅Π½ΡΠΊΠΎΠΉ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΠΈ. ΠΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π΄ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ ΠΊΠ»ΡΡΠ΅Π²ΡΡ ΡΠΎΠ»Ρ Π²ΠΈΡΡΡΠ° ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° (ΠΠΠ§) Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ Π Π¨Π. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΠΠ ΠΠΠ§ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΠΊΠ°Π½ΡΠ΅ΡΠΎΠ³Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΡΠ²Π»ΡΠ΅ΡΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³ΠΎΠ²ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π΄Π»Ρ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΌ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π½Π΅ΠΎΠΏΠ»Π°Π·ΠΈΠΈ. ΠΠ΄Π½Π°ΠΊΠΎ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΠΏΡΠ΅Π΄ΡΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠ½Π°Ρ ΡΠ΅Π½Π½ΠΎΡΡΡ ΡΠ°ΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎ Π²ΡΡΠΎΠΊΠ°. ΠΠ½Π°Π»ΠΈΠ· Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° (Π²ΠΈΡΡΡΠ½Π°Ρ Π½Π°Π³ΡΡΠ·ΠΊΠ°, ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ ΡΠΏΠΈΡΠΎΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΠΈ ΠΈΠ½ΡΠ΅Π³ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠΎΡΠΌ Π²ΠΈΡΡΡΠ°, Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ Π΅Π³ΠΎ ΠΏΠ΅ΡΡΠΈΡΡΠ΅Π½ΡΠΈΠΈ) ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ Π΄Π»Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ ΠΠΠ§-ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
ΠΏΠΎΡΠ»Π΅Π΄Π½Π΅Π³ΠΎ Π΄Π΅ΡΡΡΠΈΠ»Π΅ΡΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΠΠ§ ΠΈΠ½Π΄ΡΡΠΈΡΡΠ΅Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Ρ ΠΌΠΈΠΊΡΠΎΠ ΠΠ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΊΠ»Π΅ΡΠΊΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΡΡΠ°ΠΆΠ°ΡΡ ΡΡΠ°ΠΏΠ½ΠΎΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ ΠΌΠΎΠ³ΡΡ ΠΈΠΌΠ΅ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ / ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅. Π ΠΎΠ±Π·ΠΎΡΠ΅ ΠΊΡΠ°ΡΠΊΠΎ ΠΈΠ·Π»ΠΎΠΆΠ΅Π½Ρ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΎΠ± ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡΡ
ΠΏΡΠΎΡΠΈΠ»Ρ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΠΌΠΈΠΊΡΠΎΠ ΠΠ, Π²ΡΠ·ΡΠ²Π°Π΅ΠΌΡΡ
ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΠΠ§ ΡΠΏΠΈΡΠ΅Π»ΠΈΡ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ, ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½Ρ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΠ΅ ΠΏΡΠΈΠΌΠ΅ΡΡ ΡΡΠ°ΡΡΠΈΡ ΠΌΠΈΠΊΡΠΎΠ ΠΠ Π² ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΌ ΠΊΠ°Π½ΡΠ΅ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ ΠΈ ΠΎΠ±ΠΎΠ·Π½Π°ΡΠ΅Π½Ρ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΈΠΊΡΠΎΠ ΠΠ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π±ΠΈΠΎΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ Π Π¨Π.
- β¦